Hundreds of network terminations reversed or avoided.
A PBM "termination for cause" notice carries across affiliated networks. Within 30 days, your pharmacy can lose Medicare Part D, Medicaid MCO, and commercial access. The pharmacy's market value collapses to its DEA license and physical assets. Buyers walk.
Health Law Alliance has reversed or avoided hundreds of PBM network terminations across pharmacies nationwide — including seven OptumRx reversals for New York independent pharmacies in 2024 and a Michigan reversal in 2025. The appeal window is short, sometimes shorter than the notice suggests. We defend network termination matters from the day the notice arrives.
.png)
A six-figure recoupment is recoverable. A network termination is existential. The 30-day notice runs whether or not the appeal is filed, and the consequences cascade across affiliated networks, credentialing records, and business value.
An OptumRx termination ends Medicare Part D, UnitedHealthcare commercial, and many Medicaid MCO lines within 30 days. A Caremark termination cascades to SilverScript and Aetna. A single termination notice often becomes three to five separate network losses within the same quarter.
A "termination for cause" designation appears in the National Council of Prescription Drug Programs (NCPDP) credentialing record and follows the pharmacy across every future credentialing application. New PBMs run pre-credentialing checks against this record before extending network access.
A pharmacy with active PBM network access typically sells for 1x to 2.5x annual revenue. A pharmacy that has lost its primary PBM networks sells for the value of inventory, fixtures, and the DEA license. Most acquirers walk on the day the termination is disclosed in diligence.
An audit response addresses dollars. A termination response addresses the existence of the pharmacy. The procedural posture, the evidentiary standard, and the resolution mechanism are all different.
Our bench includes former senior executives at OptumRx and other major PBMs. We know how PBM network relations and credentialing teams make termination decisions because we made them. This is how we reverse them.
Within 24 hours: confirm the termination basis cited in the notice, calendar every appeal deadline, identify the affiliated networks at risk, and preserve the underlying audit record. Most pharmacies miss appeal-window dates buried inside the notice. We do not.
A network termination appeal is two arguments at once: the audit findings cited as predicate are wrong on the merits, and even if they were right, they do not legally support termination under the network contract. Both arguments go in the appeal brief. We have built this two-track brief eight times.
Most successful reinstatements happen at the network-relations level before the formal appeal escalates to litigation. Direct engagement with the PBM's network team, framed as the procedural and substantive case the appeal will make, often produces resolution faster than the formal track. Our former-PBM-executive bench is what makes this possible.
When the PBM refuses reasonable resolution and the termination effective date is imminent, we file in federal court. Emergency TRO actions can pause the termination while the merits are litigated. Federal court is the backstop, not the first move, but it is the move PBMs respect.
If any of these describe your last twelve months of PBM activity, the termination notice may already be drafted. PBMs build the basis before they send the notice.
Outcomes are summarized for confidentiality. Client names, precise geography, and identifying facts are redacted.
Network Reinstated
Seven independent pharmacies in New York received OptumRx "termination for cause" notices in a single quarter, all citing related audit findings. Health Law Alliance built a coordinated appeal record across the seven matters, engaged OptumRx network relations directly, and secured full network reinstatement for each pharmacy.
Network Reinstated
Michigan independent pharmacy faced an OptumRx termination tied to audit findings on specialty drug dispensing. Health Law Alliance challenged the audit findings on extrapolation methodology and the termination basis on contractual grounds; OptumRx reversed the termination and the pharmacy continued operating without interruption.
Single-location pharmacy received a Caremark "termination for cause" notice tied to compounded semaglutide dispensing during the FDA shortage period. Health Law Alliance's appeal brief led to full reinstatement across Caremark, SilverScript and Aetna networks, with no recoupment imposed.
Attorney advertising. Prior results do not guarantee a similar outcome. Case summaries are generalized for confidentiality and are not a substitute for legal advice on your specific matter.
Anthony's background as a former federal prosecutor and executive for major healthcare companies provided a level of expertise and insight that made all the difference. His deep understanding of healthcare law, particularly in litigation and compliance matters, helped navigate complex legal issues with ease.
Seven questions that come up on almost every first call. The answers below are general; specific situations require privileged consultation.
Before the termination effective date, before patients are redirected to other pharmacies, before buyers walk away from the deal, have a privileged conversation with attorneys who have reversed or avoided hundreds of PBM terminations. Free, confidential, no retainer.
